Success Story: Advancing Vascular and Neurovascular Disease Research Leads to I-140 NIW Approval
Client’s Testimonial:
"Thank you very much for your kind message and for all of your support throughout my NIW process. I truly appreciate the efforts of everyone on your team, and I am grateful to have achieved this milestone with your guidance.”
On June 13th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Research Associate in the Field of Biomedical Sciences (Approval Notice).
General Field: Biomedical Sciences
Position at the Time of Case Filing: Research Associate
Country of Origin: South Korea
State of Residence at the Time of Filing: Louisiana
Approval Notice Date: June 13th, 2026
Processing Time: 4 months, 15 days (Premium Processing Upgrade Requested)
Case Summary:
We are pleased to share that the client’s I-140 National Interest Waiver petition was approved. The client holds an M.P.H. and has developed a research record in biomedical sciences, with particular emphasis on vascular biology, disease modeling, and translational approaches that may support more precise therapies for serious vascular and neurovascular conditions.
The petition centered on the client’s proposed endeavor: continuing research on developing iPSC-derived vascular and brain organoid models integrated with molecular profiling, genome editing, and advanced vascular assays. In the petition, this endeavor was framed as important not only because of its scientific complexity, but because it addresses disease mechanisms connected to public health, precision medicine, and long-term healthcare burdens.
At the time of filing, the client was employed in a research role within a health sciences setting, where the client’s ongoing work involved stem cell-derived endothelial and vascular organoid models, molecular and cellular analyses, barrier function assays, and collaborative biomedical research. The petition made clear that the NIW request was not based on a single job offer, but on the broader national value of the client’s proposed research direction.
To show that the client was well-positioned to advance the endeavor, we highlighted a balanced record of scholarly and applied contributions. The evidence included 3 peer-reviewed journal articles, 1 first-authored peer-reviewed conference article, 2 abstracts, including 1 first-authored abstract, and 5 granted patents. The client’s published body of work had received 10 citations. While this citation count was not presented as automatically decisive, the petition explained how an adjudicator could view it in context: the citations showed that other researchers had begun using the client’s findings, and one publication was positioned favorably when compared with citation averages for its field and year.
The petition also addressed the client’s significance through evidence beyond publication numbers. The record included research connected to a major federal biomedical funding source, which supported the argument that the client’s work aligned with recognized research priorities. In addition, the petition relied on 3 letters of recommendation to explain the client’s role, technical expertise, and continuing value to the field. These letters helped connect the client’s accomplishments to the proposed endeavor rather than treating the metrics alone as proof of eligibility.
Ultimately, the petition demonstrated that the client’s work had substantial merit and national importance, that the client was well-positioned to continue the research, and that waiving the job offer and labor certification requirements would benefit the United States. We congratulate the client on this I-140 NIW approval and wish the client continued success in advancing biomedical research with potential value for vascular and neurovascular health.